# Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)

> **NCT03410407** · — · TERMINATED · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 21 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **OTHER:** Observation of CNS involvement

## Key facts

- **NCT ID:** NCT03410407
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-19
- **Primary completion:** 2020-06-05
- **Final completion:** 2020-06-05
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** lack of interest
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03410407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03410407, "Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03410407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*